Psoriatic arthritis

New prediction tool identifies methotrexate non responders

UK researchers have developed what they say is the first model to identify patients who will not respond to methotrexate based on ‘real world data’. The model has flagged anxiety as a significant overlooked predictor of non-response to the conventional DMARD within six months of starting treatment. Writing in Arthritis Research & Therapy, the researchers ...

Already a member?

Login to keep reading.

© 2021 the limbic